Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yuen

Showing results (141-150 of 351) with videos related to

Pageof 36
Sort By:
Frontiers in Endocrinology|December 12, 2024
Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulinKevin C J Yuen, Rikke Hjortebjerg, Ashok Ainkaran Ganeshalingam, et al.
Hepatology (Baltimore, Md.)|May 27, 2016
Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in miceSeung-Ah Lee, Jason J Yuen, Hongfeng Jiang, et al.
Hepatobiliary Surgery and Nutrition|July 8, 2015
DGAT1-deficiency affects the cellular distribution of hepatic retinoid and attenuates the progression of CCl4-induced liver fibrosisJason J Yuen, Seung-Ah Lee, Hongfeng Jiang, et al.
Clinical Pharmacokinetics|February 16, 1999
Clinical pharmacokinetics of lamivudineM A Johnson, K H Moore, G J Yuen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2020
Cost-Effectiveness and Efficacy of a Novel Combination Regimen in Acromegaly: A Prospective, Randomized TrialVivien Bonert, James Mirocha, John Carmichael, et al.
Asian Journal of Surgery|October 12, 2002
Improved detection rate of prostate cancer using the 10-core biopsy strategy in SingaporeL G Ng, S Yip, P H Tan, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapyJ Mittler, P Essunger, G J Yuen, et al.
Endocrinology, Diabetes & Metabolism|July 16, 2021
Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemicKevin C J Yuen, Michael J Mortensen, Amir Azadi, et al.
Health Education Research|September 2, 2006
Risk perceptions and behavioral intentions for Hepatitis B: how do young adults fare?Rm Gonzales, Dc Glik, M Prelip, et al.
Pharmacotherapy|April 20, 2001
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adultsA C Crémieux, C Katlama, C Gillotin, et al.
Pageof 36

Showing results (141-150 of 351) with videos related to

Sort By:
Pageof 36
Frontiers in Endocrinology|December 12, 2024
Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulinKevin C J Yuen, Rikke Hjortebjerg, Ashok Ainkaran Ganeshalingam, et al.
Hepatology (Baltimore, Md.)|May 27, 2016
Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in miceSeung-Ah Lee, Jason J Yuen, Hongfeng Jiang, et al.
Hepatobiliary Surgery and Nutrition|July 8, 2015
DGAT1-deficiency affects the cellular distribution of hepatic retinoid and attenuates the progression of CCl4-induced liver fibrosisJason J Yuen, Seung-Ah Lee, Hongfeng Jiang, et al.
Clinical Pharmacokinetics|February 16, 1999
Clinical pharmacokinetics of lamivudineM A Johnson, K H Moore, G J Yuen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2020
Cost-Effectiveness and Efficacy of a Novel Combination Regimen in Acromegaly: A Prospective, Randomized TrialVivien Bonert, James Mirocha, John Carmichael, et al.
Asian Journal of Surgery|October 12, 2002
Improved detection rate of prostate cancer using the 10-core biopsy strategy in SingaporeL G Ng, S Yip, P H Tan, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapyJ Mittler, P Essunger, G J Yuen, et al.
Endocrinology, Diabetes & Metabolism|July 16, 2021
Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemicKevin C J Yuen, Michael J Mortensen, Amir Azadi, et al.
Health Education Research|September 2, 2006
Risk perceptions and behavioral intentions for Hepatitis B: how do young adults fare?Rm Gonzales, Dc Glik, M Prelip, et al.
Pharmacotherapy|April 20, 2001
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adultsA C Crémieux, C Katlama, C Gillotin, et al.
Pageof 36